Navigation Links
Ruedi Waeger Receives the 2010 Robert W. Reilly Leadership Award from Plasma Protein Therapeutics Association
Date:6/25/2010

RESEARCH TRIANGLE PARK, N.C., June 25 /PRNewswire-FirstCall/ -- Ruedi Waeger, Ph.D., former president and CEO of Aventis Behring LLC and a member of the Talecris Board of Directors, was honored with the Robert W. Reilly Leadership award June 15 at the 2010 Plasma Protein Forum in Reston, VA.

The award is sponsored by the Plasma Protein Therapeutics Association (PPTA) and recognizes individuals who exemplify the leadership qualities of Robert Reilly, former leader of the PPTA. Reilly's efforts improved the quality of plasma products in the U.S. and enhanced the reputation of the plasma therapeutics industry worldwide.

Waeger was bestowed the award because of his significant contributions toward improving patient access to therapies, ensuring the highest quality and safety of plasma-derived products, and striving to achieve worldwide regulatory standardization of protein therapies.

"Ruedi's accomplishments throughout his 30-year career have contributed immensely to the field of protein therapeutics, and we are pleased that his accomplishments have been recognized by the industry," said Lawrence D. Stern, chairman and CEO of Talecris. "Ruedi's breadth of knowledge and experience continue to be tremendously valuable to Talecris, and we congratulate him on having received this honor from the PPTA."

Waeger has served on the Talecris Board since April 2005 and currently chairs the compliance committee. He also serves on the nominating and governance committees.  Waeger has more than 30 years of experience in the global pharmaceutical and therapeutic protein industries. Prior to joining the Talecris board, Waeger served as President and CEO of the plasma therapeutics company Aventis Behering LLC. Prior to that, he served as President and CEO of ZLB Central Laboratories and the Blood Transfusion Service of the Swiss Red Cross. Waeger earned a Ph.D. in biochemistry from the Swiss Federal Institute of Technology.

About the Robert W. Reilly Leadership Award

Robert Reilly was a leader in the plasma therapeutics industry association from 1992 to 1998. He created the first educational programs and industry symposia to confront the challenges facing the plasma industry worldwide. He also contributed significantly to the development of voluntary industry standards for quality plasma programs throughout the U.S., and his work helped open communications and build relationships with regulatory authorities and consumer groups.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com


'/>"/>
SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shire Receives CHMP Positive Opinion for VPRIV(TM) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease in the European Union
2. Corgenix Receives Additional European Patent, Announces Publication of Important Clinical Study on AtherOx(R) Technology
3. Aeterna Zentaris Receives US$12 Million on Closing of Registered Direct Offering
4. Nile Therapeutics Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule
5. Alexandria Real Estate Equities, Inc. Receives Final Approval From City of Cambridge to Develop Its East Cambridge State-of-the-Art Life Science Community
6. Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
7. Fenwal Scientist Receives Research Award for Work on Photopheresis Therapy
8. China Sky One Medical Receives GMP Re-Certification
9. SyntheMed Receives CE Mark Approval for REPEL-GYN™
10. Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreichs Ataxia
11. Biomedical Structures Receives Growth Capital from Ampersand Ventures to Fund Ongoing Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2017)... (PRWEB) , ... July 17, 2017 , ... ... diagnostics company that has developed and intends both to manufacture and sell reagents ... on the NASDAQ Capital Market. , Headquartered in Sandy, Utah, Co-Diagnostics’ intellectual property ...
(Date:7/15/2017)... ... ... Cuvette manufacturer FireflySci has been making many products for the ... have learned that their biggest asset was their amazing customer base. Through listening ... to meet the changing needs of scientists at a rapid pace. , For decades, ...
(Date:7/14/2017)... ... July 14, 2017 , ... Diagenode and PreOmics ... to clean peptides for mass spectrometry (MS) analysis combining the PreOmics in-StageTip Kit ... Kit is based on proprietary technology that contains optimized buffer systems permitting ultrafast ...
(Date:7/13/2017)... ... July 13, 2017 , ... FireflySci Inc. ... Blast forward seven years and now they are home to a tremendous ... for wavelength accuracy, and resolution testing. , One mega advantage that ...
Breaking Biology Technology:
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... 11, 2017 No two people are ... the New York University Tandon School of Engineering ... found that partial similarities between prints are common ... mobile phones and other electronic devices can be ... vulnerability lies in the fact that fingerprint-based authentication ...
Breaking Biology News(10 mins):